TMAO and the gut microbiome: implications for the CVD-CKD-IBD axis
Trimethylamine N-oxide (TMAO) is a metabolite produced by the gut microbiome from dietary nutrients such as choline and carnitine. Recent research has found that TMAO is strongly associated with cardiovascular disease (CVD), chronic kidney disease (CKD) and, more recently, inflammatory bowel disease...
Saved in:
| Main Authors: | Si Hyoung Kim, Mi Young Yoon, Sang Sun Yoon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2522324 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TMAO metaorganismal pathway and chronic inflammatory diseases
by: Zeneng Wang, et al.
Published: (2025-06-01) -
Multiomics-Based Profiling of the Fecal Microbiome Reveals Potential Disease-Specific Signatures in Pediatric IBD (PIBD)
by: Anita H. DeSantis, et al.
Published: (2025-05-01) -
Precision microbiota therapy for IBD: premise and promise
by: Manabu Nagayama, et al.
Published: (2025-12-01) -
The Influence of polycyclic aromatic hydrocarbons exposure on the gut microbiome composition and inflammatory responses
by: Song Hee Jeong, et al.
Published: (2025-09-01) -
Microbes with higher metabolic independence are enriched in human gut microbiomes under stress
by: Iva Veseli, et al.
Published: (2025-05-01)